cionin: disulfotyrosyl hybrid of cholecystokinin & gastrin; from the neural ganglion of the protochordate Ciona intestinalis; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 3083069 |
MeSH ID | M0174256 |
Synonym |
---|
126985-56-6 |
caerulein, 1-de(5-oxo-l-proline)-2-de-l-glutamine-3-l-asparagine-5-(o-sulfo-l-tyrosine)- |
1-de(5-oxo-l-proline)-2-de-l-glutamine-3-l-asparagine-5-(o-sulfo-l-tyrosine)caerulein |
asn-tyr(so3)-tyr(so3)-gly-trp-met-asp-phe-nh2 |
cionin |
4-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2,4-diamino-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]acetyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-4- |
Cionin is a homolog of vertebrate cholecystokinin/gastrin that has been identified in the ascidian Ciona intestinalis type A. It is a potent and efficient stimulator of gastric histamine release and acid secretion.
Excerpt | Reference | Relevance |
---|---|---|
"Cionin is a homolog of vertebrate cholecystokinin/gastrin that has been identified in the ascidian Ciona intestinalis type A. " | ( Cionin, a vertebrate cholecystokinin/gastrin homolog, induces ovulation in the ascidian Ciona intestinalis type A. Matsubara, S; Miyasaka, N; Osugi, T; Satake, H; Shiraishi, A, 2021) | 3.51 |
"Cionin is a potent and efficient stimulator of gastric histamine release and acid secretion interacting via a CCK-B receptor." | ( Effect of cionin on histamine and acid secretion by the perfused rat stomach. Johnsen, AH; MÃ¥rvik, R; Rehfeld, JF; Sandvik, A; Waldum, HL, 1994) | 2.13 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (73.33) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.86) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 3 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |